1. Top-down synthetic biology approach for titer improvement of clinically important antibiotic daptomycin in Streptomyces roseosporus
- Author
-
Hahk-Soo Kang, Haeun Kwon, Hiyoung Kim, Dongho Lee, Hyun-Woo Je, and Chang-Hun Ji
- Subjects
Streptomyces roseosporus ,Operon ,Lipopeptide ,Bioengineering ,Computational biology ,Biology ,Secondary metabolite ,biology.organism_classification ,Applied Microbiology and Biotechnology ,Streptomyces ,Anti-Bacterial Agents ,Synthetic biology ,chemistry.chemical_compound ,Daptomycin ,chemistry ,Multigene Family ,medicine ,Direct repeat ,Synthetic Biology ,Gene ,Biotechnology ,medicine.drug - Abstract
Secondary metabolites are produced at low titers by native producers due to tight regulations of their productions in response to environmental conditions. Synthetic biology provides a rational engineering principle for transcriptional optimization of secondary metabolite BGCs (biosynthetic gene clusters). Here, we demonstrate the use of synthetic biology principles for the development of a high-titer strain of the clinically important antibiotic daptomycin. Due to the presence of large NRPS (non-ribosomal peptide synthetase) genes with multiple direct repeats, we employed a top-down approach that allows transcriptional optimization of genes in daptomycin BGC with the minimum inputs of synthetic DNAs. The repeat-free daptomycin BGC was created through partial codon-reprogramming of a NRPS gene and cloned into a shuttle BAC vector, allowing BGC refactoring in a host with a powerful recombination system. Then, transcriptions of functionally divided operons were sequentially optimized through three rounds of DBTL (design-build-test-learn) cycles that resulted in up to ~2300% improvement in total lipopeptide titers compared to the wild-type strain. Upon decanoic acid feeding, daptomycin accounted for ∼ 40% of total lipopeptide production. To the best of our knowledge, this is the highest improvement of daptomycin titer ever achieved through genetic engineering of S. roseosporus. The top-down engineering approach we describe here could be used as a general strategy for the development of high-titer industrial strains of secondary metabolites produced by BGCs containing genes of large multi-modular NRPS and PKS enzymes.
- Published
- 2022